| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/18/2009 | US20090155221 Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |
| 06/18/2009 | US20090155219 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 06/18/2009 | US20090155218 Compositions and methods for growth of embryonic stem cells |
| 06/18/2009 | US20090155216 Grafting Material and Agent for Improvement in bone Quality |
| 06/18/2009 | US20090155208 Methods and agents for modulating an immune response |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | US20090155165 Anti-igf-i receptor antibody |
| 06/18/2009 | US20090151600 Adhesive protein extracted from Mytilus galloprovincialis, Mytilus galloprovincialis foot protein-5; can be used as medical adhesives as they are non-toxic to the human body and do not impose immunogenicity; water-resistant bioadhesives |
| 06/18/2009 | CA2709209A1 Method for producing dendritic cells |
| 06/18/2009 | CA2708790A1 Remedies for pemphigus containing anti fas ligand antibodies |
| 06/18/2009 | CA2708780A1 Small molecules for neuronal differentiation of embryonic stem cells |
| 06/18/2009 | CA2708343A1 Method for increasing immunoreactivity |
| 06/17/2009 | EP2071023A2 Novel enzyme |
| 06/17/2009 | EP2071021A2 Bone marrow-derived neuronal cells |
| 06/17/2009 | EP2071020A2 Tissue Implant |
| 06/17/2009 | EP2070949A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 06/17/2009 | EP2070947A1 Therapeutic and diagnostic anti-Hsp70 antibodies |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP2070542A2 Method of extended culture of antigen-specific cyotoxic T lymphocytes |
| 06/17/2009 | EP2069489A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 06/17/2009 | EP2069481A2 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 06/17/2009 | EP2069480A2 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 06/17/2009 | EP2069479A1 Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
| 06/17/2009 | EP2069478A2 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 06/17/2009 | EP2069477A2 Chemorepulsion of cells |
| 06/17/2009 | EP2069379A2 Methods for improving antibody production |
| 06/17/2009 | EP2068923A2 Antibodies with decreased deamidation profiles |
| 06/17/2009 | EP2068922A2 Anti-il-13r alpha 1 antibodies and their uses thereof |
| 06/17/2009 | EP2068921A2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 06/17/2009 | EP2068909A2 Modified fgf-21 polypeptides and their uses |
| 06/17/2009 | EP2068889A1 Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
| 06/17/2009 | EP2068887A2 Sp35 antibodies and uses thereof |
| 06/17/2009 | EP2068614A2 Method and device for micropropagation of plants |
| 06/17/2009 | EP2029177A4 Method and system for preparing soft tissue for grafting, enhancing grafting results, and grafting autologous fat and adipocyte derived stem cells to soft tissue such as the breast and other tissue defects |
| 06/17/2009 | EP1943263A4 Methods of reducing repeat-induced silencing of transgene expression and improved fluorescent biosensors |
| 06/17/2009 | EP1802759A4 Construct of swine vesicular disease virus like particle using genetic engineering and the method for manufacturing thereof |
| 06/17/2009 | EP1716228A4 System and method of up-regulating bone morphogenetic protein (bmp) gene expression in bone cells via the appplication of fields generated by specific and selective electric and electromagnetic signals |
| 06/17/2009 | EP1709571A4 System and method for plant identification |
| 06/17/2009 | EP1527341B1 Interfacial biomaterials |
| 06/17/2009 | EP1438400B1 Multi-chain eukaryotic display vectors and uses thereof |
| 06/17/2009 | EP1436384B1 Mutated abl kinase domains |
| 06/17/2009 | EP1409544B1 Human dr4 antibodies and uses thereof |
| 06/17/2009 | EP1208208B1 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 06/17/2009 | EP1179003B1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
| 06/17/2009 | EP1177304B1 Modified factor viia polypeptides |
| 06/17/2009 | EP1135511B1 Phosphonate metabolizing plants |
| 06/17/2009 | EP1124590B1 Enzyme-mediated modification of fibrin for tissue engineering |
| 06/17/2009 | EP0968277B1 Filtration method for separating viruses |
| 06/17/2009 | CN101460610A Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/17/2009 | CN101460054A Mature dendritic cell compositions and methods for culturing same |
| 06/17/2009 | CN100500855C Method for producing material of transgenic plant in use for preventing bowel complaint of babies |
| 06/17/2009 | CN100500835C Preservative fluid for exfoliative cell |
| 06/17/2009 | CN100500834C Process for breaking cell or breaking wall |
| 06/17/2009 | CA2610324A1 Stem cells methods, technologies, vertical processes |
| 06/16/2009 | US7547832 Inbred maize line PHEGV |
| 06/16/2009 | US7547831 Inbred maize line PHGJB |
| 06/16/2009 | US7547830 Inbred maize line PH4RD |
| 06/16/2009 | US7547829 Inbred maize line PHBBK |
| 06/16/2009 | US7547827 Plants and seeds of corn variety CV728154 |
| 06/16/2009 | US7547826 Plants and seeds of corn variety CV619952 |
| 06/16/2009 | US7547825 Inbred corn line PHCJP |
| 06/16/2009 | US7547820 Method for altering the nutritional content of plant seed |
| 06/16/2009 | US7547817 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen |
| 06/16/2009 | US7547816 Genetically engineered, galactosyltransferase deficient, pigs for use as source of organs, tissues and cells for xenotransplantation |
| 06/16/2009 | US7547774 RCc3 regulatory elements for use in plants |
| 06/16/2009 | US7547773 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer |
| 06/16/2009 | US7547768 Anti-TAT 113 antibodies |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547719 Thrombopoietin mimetic; useful as an agonist of the TPO receptor, particularly in enhancing platelet production; treatment of thrombocytopenia |
| 06/16/2009 | US7547674 By stimulating resident somatic stem cells; administering cytokines; kits |
| 06/16/2009 | US7547549 Method to produce a hybrid cell having a single mitochondrial genotype |
| 06/16/2009 | US7547548 Reprogramming plant development to allow flower buds and seeds to arise de novo, directly from a cotyledon or radicle explants or from shoots produced on a cotyledon or radicle |
| 06/16/2009 | US7547547 Bioprocess for producing uniform embryoid bodies from embryonic stem cells in a high density bioreactor |
| 06/16/2009 | US7547546 Umbillical cord extract for use in propagation of bone and adipocyte tissues; tissue engineering; tissue repair; regenerative medicine |
| 06/16/2009 | US7547545 Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
| 06/16/2009 | US7547544 Hybridoma cell line for production of immunoglobulins specific to g protein coupled receptor for use in prevention and treatment of cell proliferative disorders |
| 06/16/2009 | US7547543 Retinoid-Related Orphan Receptor (ROR) receptor response element ; drug screening |
| 06/16/2009 | US7547541 In vitro fertilisation |
| 06/16/2009 | US7547535 Mutant form of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase (PQQ) monitoring glucose level in blood, serum and urine |
| 06/16/2009 | US7547522 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells |
| 06/16/2009 | US7547513 Mutants of deoxycytidine kinase having extended enzymatic activity |
| 06/16/2009 | US7547449 using organic fluid-swellable, fibrous matrix, such as collagen, and a mineral phase such as caco3 or phosphate mineral phase to treat bone defects; once solidified a high mineral content can be achieved, with the inorganic mineral crystals embedded within the collagen fibers; synthetic bones |
| 06/16/2009 | US7547441 PAI-2 conjugates for the treatment and imaging of cancer |
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide |
| 06/16/2009 | US7547438 CD40-binding activating antibodies |
| 06/16/2009 | CA2399910C Mammalian secreted group iii phospholipase a2 |
| 06/16/2009 | CA2326327C Recombinant adeno-associated virus vector encoding alpha-1-antitrypsin serum protein |
| 06/16/2009 | CA2319437C Methods and reagents for decreasing allergic reactions |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2251391C Process for the production of plants with enhanced growth characteristics |
| 06/12/2009 | CA2646208A1 Bone marrow-derived neuronal cells |
| 06/12/2009 | CA2613945A1 Bladder bioreactor |
| 06/11/2009 | WO2009073618A2 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| 06/11/2009 | WO2009073599A1 Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells |
| 06/11/2009 | WO2009073594A1 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| 06/11/2009 | WO2009073523A2 De-differentiation of human cells |
| 06/11/2009 | WO2009073518A1 Methods of isolating non-senescent cardiac stem cells and uses thereof |
| 06/11/2009 | WO2009073501A2 System for diagnosis and treatment of photovoltaic and other semiconductor devices |